Wei Yu
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 26
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 14
- Co-authors
- Qixia Luo (12 shared papers)Yonghong Xiao (18 shared papers)Kai Zhou (9 shared papers)Ping Shen (14 shared papers)Lihua Guo (5 shared papers)Tianshui Niu (7 shared papers)Yonghong Xiao (9 shared papers)Yunqing Qiu (11 shared papers)
- Journals
- Infection and Drug Resistance (7 papers)Frontiers in Cellular and Infection Microbiology (4 papers)Drug Design Development and Therapy (3 papers)BMC Infectious Diseases (3 papers)International Journal of Antimicrobial Agents (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Yu
87 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 116
- Molecular Medicine 415
- Applied Microbiology and Biotechnology 67
- Endocrinology 170
- Anesthesiology and Pain Medicine 79
- Pharmacology 160
Countries citing papers authored by Wei Yu
This map shows the geographic impact of Wei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yu more than expected).
Fields of papers citing papers by Wei Yu
This network shows the impact of papers produced by Wei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yu. The network helps show where Wei Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Using diagnoses to describe populations and predict costs. | 2000 | 146 |
| 2 | 2018 | 112 | |
| 3 | 2017 | 83 | |
| 4 | 2021 | 67 | |
| 5 | 2010 | 60 | |
| 6 | 2019 | 54 | |
| 7 | 2019 | 37 | |
| 8 | 2017 | 36 | |
| 9 | 2006 | 35 | |
| 10 | 2017 | 33 | |
| 11 | 2018 | 31 | |
| 12 | 2018 | 29 | |
| 13 | 2020 | 29 | |
| 14 | 2021 | 27 | |
| 15 | 2019 | 27 | |
| 16 | 2004 | 27 | |
| 17 | 2021 | 26 | |
| 18 | 2022 | 25 | |
| 19 | 2021 | 24 | |
| 20 | 2021 | 21 |
About Wei Yu
Wei Yu is a scholar working on Molecular Medicine, Pharmacology, Molecular Biology, Applied Microbiology and Biotechnology and Epidemiology, having authored 94 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Use and Resistance (8 papers), Infant Nutrition and Health (7 papers), Vibrio bacteria research studies (6 papers), Bacterial biofilms and quorum sensing (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). The work is most often cited by research in Molecular Medicine (415 citations), Applied Microbiology and Biotechnology (67 citations), Endocrinology (170 citations), Anesthesiology and Pain Medicine (79 citations) and Pharmacology (160 citations). Wei Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qixia Luo, Yonghong Xiao, Kai Zhou, Ping Shen, Lihua Guo, Tianshui Niu, Yonghong Xiao, Yunqing Qiu, Yunbo Chen and Lisa I. Iezzoni. Their work appears in journals such as Infection and Drug Resistance, Frontiers in Cellular and Infection Microbiology, Drug Design Development and Therapy, BMC Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.